News & Events



OneOme announces availability of RightMed pharmacogenomic test

Comprehensive, affordable test can be ordered online by healthcare providers

Minneapolis, Minn., July 19, 2016 – Driven to improve patient care and reduce overall healthcare costs, pharmacogenomics company OneOme announces the global availability of its RightMed test.

The RightMed test is a cost-effective, comprehensive pharmacogenomic analysis of 22 genes provided as a pa...

READ MORE

Pharmacogenomics company OneOme moves steps closer to product launch

Minneapolis company announces new chief executive, headquarters and lab

Minneapolis, Minn., July 12, 2016 – In preparation for its full launch of the RightMed® pharmacogenomic test, OneOme announces Paul Owen as Chief Executive Officer and opens its new headquarters and lab in northeast Minneapolis. By mid-July, OneOme will make the RightMed test commercially availab...

READ MORE

Pharmacogenomics company OneOme achieves more key milestones

Minneapolis company announces new leadership and first exhibition

Minneapolis, Minn., June 20, 2016 – Pharmacogenomics company OneOme is pleased to announce key business milestones in advance of launching its RightMed test.

The RightMed test is a cost-effective, comprehensive, personalized pharmacogenomic analysis of 22 genes provided at the point of care. The t...

READ MORE

OneOme expands leadership team in preparation for mid-year launch of its comprehensive pharmacogenomic test

MINNEAPOLIS, March 17, 2016 /PRNewswire/ — OneOme, LLC, a pharmacogenomics company, announced today the hiring of Dr. Justin Odegaard, M.D., Ph.D. and Ross Higgins to manage and lead their pharmacogenomics testing laboratory. Both Dr. Odegaard and Mr. Higgins bring extensive background in laborato...

READ MORE